StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Geron total assets

Total assets on the balance sheet at the end of each period.

Geron's total assets was $519.01M at Jun 30, 2026. For fiscal 2025 it was $570.54M, down 3.9% from the year before. Over ten years it grew 14.4% a year on average. The highest annual figure on record is $593.78M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$570.54M-3.9%
FY2024Dec 31, 2024$593.78M+50.7%
FY2023Dec 31, 2023$394.08M+106.8%
FY2022Dec 31, 2022$190.58M-15.7%
FY2021Dec 31, 2021$226.03M-16.5%
FY2020Dec 31, 2020$270.73M+63.6%
FY2019Dec 31, 2019$165.52M-10.7%
FY2018Dec 31, 2018$185.28M+68.0%
FY2017Dec 31, 2017$110.31M-15.3%
FY2016Dec 31, 2016$130.25M-12.4%
FY2015Dec 31, 2015$148.76M-13.8%
FY2014Dec 31, 2014$172.51M+156.2%
FY2013Dec 31, 2013$67.34M-32.5%
FY2012Dec 31, 2012$99.80M-37.6%
FY2011Dec 31, 2011$160.05M-31.5%
FY2010Dec 31, 2010$233.58M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$519.01M-6.5%
Q1 FY2026Mar 31, 2026$534.12M-5.0%
Q4 FY2025Dec 31, 2025$570.54M-3.9%
Q3 FY2025Sep 30, 2025$567.38M+27.5%
Q2 FY2025Jun 30, 2025$555.20M+23.5%
Q1 FY2025Mar 31, 2025$562.45M+16.7%
Q4 FY2024Dec 31, 2024$593.78M+50.7%
Q3 FY2024Sep 30, 2024$444.95M+7.7%
Q2 FY2024Jun 30, 2024$449.40M+8.2%
Q1 FY2024Mar 31, 2024$482.07M+13.5%
Q4 FY2023Dec 31, 2023$394.08M+106.8%
Q3 FY2023Sep 30, 2023$413.02M+77.6%
Q2 FY2023Jun 30, 2023$415.30M+74.4%
Q1 FY2023Mar 31, 2023$424.88M+114.1%
Q4 FY2022Dec 31, 2022$190.58M-15.7%
Q3 FY2022Sep 30, 2022$232.61M+1.5%
Q2 FY2022Jun 30, 2022$238.16M-5.6%
Q1 FY2022Mar 31, 2022$198.42M-23.3%
Q4 FY2021Dec 31, 2021$226.03M-16.5%
Q3 FY2021Sep 30, 2021$229.10M-19.8%
Q2 FY2021Jun 30, 2021$252.18M-8.2%
Q1 FY2021Mar 31, 2021$258.61M+81.0%
Q4 FY2020Dec 31, 2020$270.73M+63.6%
Q3 FY2020Sep 30, 2020$285.79M+74.0%
Q2 FY2020Jun 30, 2020$274.81M+65.3%
Q1 FY2020Mar 31, 2020$142.89M-18.7%
Q4 FY2019Dec 31, 2019$165.52M-10.7%
Q3 FY2019Sep 30, 2019$164.25M-12.6%
Q2 FY2019Jun 30, 2019$166.23M-9.3%
Q1 FY2019Mar 31, 2019$175.67M+66.5%
Q4 FY2018Dec 31, 2018$185.28M+68.0%
Q3 FY2018Sep 30, 2018$187.93M+64.5%
Q2 FY2018Jun 30, 2018$183.27M+47.5%
Q1 FY2018Mar 31, 2018$105.51M-18.1%
Q4 FY2017Dec 31, 2017$110.31M-15.3%
Q3 FY2017Sep 30, 2017$114.24M-16.1%
Q2 FY2017Jun 30, 2017$124.28M–
Q1 FY2017Mar 31, 2017$128.85M–
Q4 FY2016Dec 31, 2016$130.25M–
Q3 FY2016Sep 30, 2016$136.23M–

More Geron figures

See a number that looks wrong?